Endocrine regulation of lung disease and inflammation
被引:54
|
作者:
Fuentes, Nathalie
论文数: 0引用数: 0
h-index: 0
机构:
Penn State Univ, Dept Pediat, Coll Med, Hershey, PA 17033 USAPenn State Univ, Dept Pediat, Coll Med, Hershey, PA 17033 USA
Fuentes, Nathalie
[1
]
Silveyra, Patricia
论文数: 0引用数: 0
h-index: 0
机构:
Penn State Univ, Dept Pediat, Coll Med, Hershey, PA 17033 USA
Penn State Univ, Dept Biochem & Mol Biol, Coll Med, Hershey, PA 17033 USAPenn State Univ, Dept Pediat, Coll Med, Hershey, PA 17033 USA
Silveyra, Patricia
[1
,2
]
机构:
[1] Penn State Univ, Dept Pediat, Coll Med, Hershey, PA 17033 USA
[2] Penn State Univ, Dept Biochem & Mol Biol, Coll Med, Hershey, PA 17033 USA
Sex-based disparities have been identified in respiratory physiology, and in many chronic lung diseases including asthma, chronic obstructive pulmonary disease, and cystic fibrosis. The observed sex differences in lung disease prevalence and incidence have been linked to changes in circulating levels of sex hormones that start after puberty and that have been shown to affect physiological and immunological functions. While the exact roles of male and female sex hormones in these processes have not been fully elucidated, it is now evident that these can target many lung cell types and affect several functions of the respiratory system. In this mini-review, we have summarized seminal studies aimed to understand the effects of the most relevant male and female sex hormones (estrogens, progesterone, and androgens) and their receptors on lung function. Moreover, we have reviewed the known influences of sex hormones and of the hypothalamic-pituitary-gonadal axis in lung disease and immunity. Understanding the roles of sex hormones in the regulation of lung function and inflammation is the first step for the potential development of more effective therapeutic options to prevent and treat lung disease in men and women.